Genome Editing Biotech EdiGene Raises $11 M in Series Pre-B2 Financing and Forms Research Collaboration to Develop Allogeneic T-cell Therapeutics for Cancer
Inscripta Appoints Jim Lalonde to Lead Microbial Digital Genome Engineering Business and Portfolio Strategy
Inscripta Expands Management Team with Appointment of Three Senior Bioinformatics and Computational Biology Experts
Research roundup: Artificial cells respond to their environment, protein nanowires, and a new CRISPR algorithm
Sangamo Announces Nature Biotechnology Publication of New Strategies for Optimizing the Specificity of Gene Editing Nucleases
